Codexis Inc (CDXS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $116.17M
Last updated: Nov 17, 2026 at 4:20 PM ET
Codexis Inc (CDXS) Statistics
Codexis (CDXS) has a market cap of $116.17M and an enterprise value of $159.27M. Its share count is up 18.85% from a year earlier. Revenue grew 66.89% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 37.10% above the market cap, as debt exceeds cash.
| Market Cap | $116.17M |
|---|---|
| Enterprise Value | $159.27M |
| Latest price (Nov 17, 2026) | $1.07 |
Key Dates
The next earnings report is expected on Mar 9, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 9, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
| Forward P/S | 1.6x |
|---|---|
| P/B Ratio | 2.2x |
| P/TBV Ratio | 2.4x |
Price Statistics
The stock is down 34.95% over 52 weeks and trades 16.41% below its 50-day average.
| Beta (1Y) | 1.65 |
|---|---|
| 52-Week Change | -34.95% |
| 1-Month Change | -18.94% |
| 3-Month Change | -33.13% |
| 6-Month Change | -56.50% |
| 5-Year Change | -96.58% |
| 10-Year Change | -76.44% |
| Total Return (1Y) | -34.95% |
| Total Return (3Y CAGR) | -19.35% |
| Total Return (5Y CAGR) | -50.84% |
| Return vs SPY (1Y) | -46.32% |
| Max Drawdown (1Y) | -66.38% |
| Max Drawdown (3Y) | -83.51% |
| Sharpe Ratio (1Y) | -0.50 |
| Correlation with SPY (1Y) | 0.26 |
| 50-Day Average | $1.28 |
| 200-Day Average | $1.79 |
| 52-Week Range | $0.90 to $2.98 |
| RSI (14 Days) | 43.6 |
| Average Volume (20 Days) | 950.56K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.81x current liabilities, and total debt is 1.41x shareholder equity.
| Current Ratio | 2.81x |
|---|---|
| Quick Ratio | 2.75x |
| Debt / Equity | 1.41x |
Returns and Efficiency
| ROE (5Y Average) | -61.75% |
|---|---|
| ROA (5Y Average) | -30.29% |
| ROIC (5Y Average) | -79.36% |
| Asset Turnover | 0.66x |
Scores
CDXS has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was $88.34M over the last 12 months.
| Revenue | $88.34M |
|---|---|
| Revenue Growth (YoY) | +66.89% |
| Gross Profit | $75.39M |
| Operating Income | -$12.74M |
| Pretax Income | -$19.16M |
| Net Income | -$19.24M |
| EBITDA | -$11.15M |
| Reported EPS (TTM) | -$0.17 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 35.53% of the $144.22M in total assets.
| Cash and Equivalents | $29.21M |
|---|---|
| Total Debt | $72.31M |
| Net Debt | $43.10M |
| Net Debt Per Share | $0.40 |
| Working Capital | $61.67M |
| Shareholder Equity | $51.24M |
| Book Value Per Share | $0.48 |
| Tangible Book Value | $48.77M |
| Tangible Book Per Share | $0.45 |
| Total Assets | $144.22M |
| Total Liabilities | $92.98M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.67M of capital spending, operating cash flow left -$12.14M of free cash flow.
| Operating Cash Flow | -$10.47M |
|---|---|
| Capital Expenditures | $1.67M |
| Free Cash Flow | -$12.14M |
| FCF Per Share | -$0.11 |
| Depreciation and Amortization | $9.72M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -14.42%, against a 5-year average of -59.39%.
| Gross Margin | 85.34% |
|---|---|
| Operating Margin | -14.42% |
| Pretax Margin | -21.69% |
| Net Margin | -21.77% |
| EBITDA Margin | -12.62% |
| FCF Margin | -13.74% |
| Gross Margin (5Y Average) | 78.48% |
| Operating Margin (5Y Average) | -59.39% |
| Net Margin (5Y Average) | -65.14% |
Growth
Revenue fell 20.22% a year over 3 years.
| Revenue Growth (3Y CAGR) | -20.22% |
|---|---|
| Revenue Growth (5Y CAGR) | +0.38% |
| Book Value Per Share Growth (2Y CAGR) | -33.22% |
| Tangible Book Per Share Growth (2Y CAGR) | -33.92% |
Analyst Forecast
Consensus estimates put revenue growth at 11.63% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +11.63% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About CDXS
What is CDXS's market cap?
Codexis has a market cap of $116.17M. Its enterprise value, which adds debt and subtracts cash, is $159.27M.
How many shares of CDXS are outstanding?
Codexis has 107.26M shares outstanding. The count is up 18.85% from a year earlier.
Does CDXS pay a dividend?
No. Codexis does not pay a dividend.
How much debt does CDXS have?
Codexis has $72.31M of total debt and $29.21M of cash and equivalents, a net debt position of $43.10M.
CDXS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors